SIC
IDXX icon

Salem Investment Counselors’s Idexx Laboratories IDXX Stock Holding History

Salem Investment Counselors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$1.01K – 1239
2024
Q3 		$1.01K Hold
2
– – ﹤0.01% 1088
2024
Q2 		$975 Hold
2
– – ﹤0.01% 1084
2024
Q1 		$1.08K Buy
+2
New +$1.09K ﹤0.01% 1085
2022
Q1 		– Sell
-59
Closed -$39K – 1046
2021
Q4 		$39K Buy
+59
New +$37K ﹤0.01% 600
2021
Q1 		– Sell
-40
Closed -$20K – 881
2020
Q4 		$20K Buy
+40
New +$17.9K ﹤0.01% 577

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Salem Investment Counselors's IDXX Position: Q4 2024 in Review

Salem Investment Counselors sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 2 shares — an estimated $1.01K sold.

Salem Investment Counselors first reported a position in IDXX in Q4 2020 and held it in 5 quarters. The position peaked at $39K in Q4 2021. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Salem Investment Counselors reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Salem Investment Counselors sold 2 Idexx Laboratories shares in Q4 2024, an estimated $1.01K.
  • Salem Investment Counselors first reported a position in Idexx Laboratories in Q4 2020 and held it in 5 quarters.
  • Salem Investment Counselors's Idexx Laboratories position peaked at $39K in Q4 2021.
  • 1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Salem Investment Counselors's 13F filing for Q4 2024, filed 13 Jan 2025.